Braid: All-consuming referendum noise masks move to patient-pay health care - Yahoo News Canada
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
The drumbeat of referendum publicity has swept many problems under the rug in this province. We're in the midst of profound and dubious changes to services that Albertans depend upon. In normal times, these would be top of mind. But the Oct. 19 vote, and the blizzard of news around it, doesn't leave much breathing room. Radical upheaval is bubbling, especially in health care. The key points are:• Health insurance changes that threaten higher costs for medications;• A private surgery system that will bleed doctors from the public system;• Explosive and controversial expansion of private surgery clinics;• Radical restructuring of AISH. Much of this came into full effect Sept. 1 with the implementation of Bill 11. All of it — every step — is fully in line with Premier Danielle Smith's determination to make Albertans pay for more of their own health care. In the 2023 election, confronted with her earlier views on this subject, she pledged:"You will never use a credit card to pay for a public health-care service. "No Albertan will ever have to pay out of pocket to see their family doctor or to get the medical treatment they need.
This article is an excerpt. To read the full content, visit the original source. Yahoo News Canada
Related articles
Braid: All-consuming referendum noise masks move to patient-pay health care - Calgary Herald
Skip to Content Subscribe FAQ My Account Manage My Subscription News Local News Crime Politics True Crime National World Weather Archives Business Energy Local Business Real Estate First-Time Homebuyers Commercial Real Estate FP Markets FP Headlines FP Money Technology Gaming Science Space Small Business Alberta's Top Employers Sports Calgary Flames NHL PWHL More Hockey Calgary Stampeders CFL NFL Calgary Cavalry Calgary Roughnecks Spruce Meadows Soccer International Soccer MLS Baseball Basketball Golf Golf Videos Curling Rodeo-Chucks Tennis Auto Racing Opinion Columnists Letters Editorials Send us an Opinion Column or Letter Arts Local Arts Movies Movie Listings Television TV Listings Theatre Music Celebrity Books Life Health Women Men Sexual Health Diet & Fitness Family & Child Special Sections CALGARY HOME + GARDEN SHOW Encore Lifestyles CALGARY FALL HOME SHOW Food Homes New Homes Condos Rec Properties Calgary Homes & Design Fashion & Beauty Parenting Relationships Advice Horoscopes Royals Travel Ski & Snowboard Travel Alberta Travel Canada Travel USA Travel International Cruises Travel Essentials Savings Contests Readers' Choice Lives Told Tails Told Shopping Calgary Herald
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!